LEMAITRE VASCULAR, INC. Contingent Consideration Classified as Equity, Fair Value Disclosure
LEMAITRE VASCULAR, INC. (LMAT) had Contingent Consideration Classified as Equity, Fair Value Disclosure of $100.00 thousand as of 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Notes › Fair Value Disclosures
us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure · last filed 2014-11-06
- 2014-09-30: Contingent Consideration Classified as Equity, Fair Value Disclosure $100.00K.
- 2014-06-30: Contingent Consideration Classified as Equity, Fair Value Disclosure $200.00K.
| Period end | Contingent Consideration Classified as Equity, Fair Value Disclosure |
|---|---|
| 2014-09-30 | $100.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $200.00K 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |